Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	122.67	183.05	226.32	286.47	378.69	465.83
Short-Term Investments	49	49.39	50.08	49.94	126.28	12.03
Cash & Short-Term Investments	171.67	232.43	276.4	336.41	504.97	477.86
Cash Growth	-33.24%	-15.91%	-17.84%	-33.38%	5.67%	64.78%
Accounts Receivable	64.15	57.02	34.9	44.06	40.29	28.55
Inventory	33.52	28.31	24.08	32.06	39.31	31.8
Other Current Assets	54.1	15.2	11.4	11.72	11.91	8.28
Total Current Assets	323.44	332.97	346.78	424.26	596.48	546.5
Net Property, Plant & Equipment	181.88	151.66	161.35	203.36	214.39	105.7
Other Intangible Assets	13	13.43	14.48	54.48	59.74	18.26
Goodwill	82.2	82.19	85.81	85.81	85.81	22.43
Long-Term Investments	68.09	54.34	1.53	-	-	-
Other Long-Term Assets	7.62	7.28	4.38	8.49	4.96	9.2
Total Assets	676.21	641.86	614.32	776.4	961.38	702.1
Accounts Payable	14.68	11.09	1.63	14.05	20.09	14.9
Accrued Expenses	27	54.34	48.75	36.57	37.19	28.76
Current Portion of Long-Term Debt	-	-	-	-	-	1.55
Current Portion of Leases	10.44	13.82	14.81	14.9	13.64	8.21
Other Current Liabilities	67.85	12.15	5.82	7.8	19.74	9.62
Total Current Liabilities	119.98	91.41	71.01	73.32	90.66	63.05
Long-Term Leases	85.4	42.75	70.22	79.17	81.27	53.16
Other Long-Term Liabilities	15.75	34.75	0.41	0.48	0.06	5.07
Total Long-Term Liabilities	101.14	77.5	70.63	79.65	81.33	58.22
Total Liabilities	221.12	168.9	141.63	152.97	171.99	121.28
Additional Paid-in Capital	1,850	1,793	1,715	1,657	1,620	1,191
Accumulated Other Comprehensive Income	-0.64	-0.63	-0.62	-0.76	-1.84	0.55
Retained Earnings	-1,394	-1,320	-1,242	-1,033	-828.42	-610.55
Shareholders' Equity	455.09	472.96	472.69	623.43	789.39	580.82
Total Liabilities & Equity	676.21	641.86	614.32	776.4	961.38	702.1
Total Debt	95.84	56.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	75.83	175.86	191.37	242.34	410.06	414.94
Net Cash Growth	-56.88%	-8.11%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	1.24	2.94	3.30	4.26	7.61	8.60
Book Value	455.09	472.96	472.69	623.43	789.39	580.82
Book Value Per Share	7.45	7.91	8.15	10.96	14.65	12.04
Tangible Book Value	359.9	377.34	372.4	483.14	643.84	540.13
Tangible Book Value Per Share	5.89	6.31	6.42	8.49	11.95	11.19

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q